Total Payments
$2,262
2024 Payments
$751.75
Companies
17
Transactions
119
Medicare Patients
2,191
Medicare Billing
$190,934
Payment Breakdown by Category
Food & Beverage$2,262 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,262 | 119 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $820.57 | 48 | $0 (2024) |
| GlaxoSmithKline, LLC. | $240.70 | 6 | $0 (2024) |
| Daiichi Sankyo Inc. | $213.06 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $195.25 | 9 | $0 (2024) |
| Lilly USA, LLC | $165.01 | 8 | $0 (2024) |
| Axsome Therapeutics, Inc. | $114.59 | 4 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $96.42 | 5 | $0 (2023) |
| Novo Nordisk Inc | $70.95 | 4 | $0 (2023) |
| Abbott Laboratories | $70.75 | 4 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $58.11 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $751.75 | 40 | ABBVIE INC. ($363.17) |
| 2023 | $936.02 | 49 | AbbVie Inc. ($236.80) |
| 2022 | $574.20 | 30 | ABBVIE INC. ($220.60) |
All Payment Transactions
119 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/05/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.14 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.70 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.44 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.35 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Respiratory | ||||||
| 08/22/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.04 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.52 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: NEUROSCIENCE | ||||||
| 07/04/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $29.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/23/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Iron Deficiency Anemia | ||||||
| 05/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 873 | 1,393 | $216,224 | $80,571 |
| 2022 | 8 | 581 | 908 | $166,416 | $63,497 |
| 2021 | 5 | 355 | 467 | $77,413 | $19,148 |
| 2020 | 6 | 382 | 453 | $76,357 | $27,718 |
Total Patients
2,191
Total Services
3,221
Medicare Billing
$190,934
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 118 | 229 | $58,853 | $19,254 | 32.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 114 | 114 | $29,982 | $14,414 | 48.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 110 | 261 | $39,150 | $12,606 | 32.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 58 | 93 | $33,573 | $11,993 | 35.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 112 | $20,384 | $6,392 | 31.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 66 | 150 | $16,950 | $5,514 | 32.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 58 | 58 | $5,800 | $4,397 | 75.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 140 | 258 | $3,870 | $2,159 | 55.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 59 | 59 | $3,835 | $1,779 | 46.4% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 13 | 13 | $2,080 | $1,220 | 58.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 16 | 17 | $986.00 | $588.54 | 59.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 12 | 16 | $384.00 | $152.32 | 39.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 13 | $377.00 | $101.43 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 141 | 315 | $79,248 | $29,349 | 37.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 102 | 102 | $26,685 | $13,038 | 48.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 51 | 71 | $25,631 | $9,895 | 38.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 70 | 81 | $14,662 | $5,002 | 34.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $9,990 | $2,996 | 30.0% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 12 | 13 | $5,369 | $2,150 | 40.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 148 | 268 | $4,020 | $792.15 | 19.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 27 | 28 | $812.00 | $274.35 | 33.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 130 | 222 | $33,958 | $9,380 | 27.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 121 | 121 | $27,026 | $5,303 | 19.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 33 | 45 | $9,857 | $2,683 | 27.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 54 | 62 | $6,298 | $1,676 | 26.6% |
About Dr. Jennifer Cutone, M.D
Dr. Jennifer Cutone, M.D is a Internal Medicine healthcare provider based in Biddeford, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1003879909.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennifer Cutone, M.D has received a total of $2,262 in payments from pharmaceutical and medical device companies, with $751.75 received in 2024. These payments were reported across 119 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,262).
As a Medicare-enrolled provider, Cutone has provided services to 2,191 Medicare beneficiaries, totaling 3,221 services with total Medicare billing of $190,934. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Biddeford, ME
- Active Since 04/11/2006
- Last Updated 09/13/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1003879909
Products in Payments
- UBRELVY (Drug) $430.13
- INJECTAFER (Drug) $213.06
- VRAYLAR (Drug) $203.72
- QULIPTA (Drug) $160.99
- AREXVY (Drug) $149.43
- FARXIGA (Drug) $147.34
- MOUNJARO (Drug) $122.57
- Auvelity (Drug) $114.59
- ENTRESTO (Drug) $77.94
- TRELEGY ELLIPTA (Drug) $75.57
- Ozempic (Drug) $70.95
- FREESTYLE LIBRE 3 (Device) $57.95
- Kerendia (Drug) $56.37
- AIRSUPRA (Drug) $47.91
- PAXLOVID (Drug) $43.79
- ELIQUIS (Drug) $39.07
- JARDIANCE (Drug) $33.81
- XARELTO (Drug) $28.00
- TEFLARO (Drug) $25.73
- SPIRIVA RESPIMAT (Drug) $24.30
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Biddeford
Dr. Peter Rubin, M.d, M.D
Internal Medicine — Payments: $31,481
Internal Medicine $31,481
Yasmin Mahal, Do, DO
Internal Medicine — Payments: $2,642
Internal Medicine $2,642
Steven Cutone, D.o, D.O
Internal Medicine — Payments: $2,606
Internal Medicine $2,606
Dr. Mahesh Bandara, M.d, M.D
Internal Medicine — Payments: $1,733
Internal Medicine $1,733
Dr. Woodrow Lee, Do, DO
Internal Medicine — Payments: $1,712
Internal Medicine $1,712
Dr. Maureen Lee, D.o, D.O
Internal Medicine — Payments: $1,636
Internal Medicine $1,636